AtriCure swings to Q3 2026 profit of $0.08 per share; Q3 2026 revenue rises 15% to $154.5 million

PUBT · 2d ago
AtriCure swings to Q3 2026 profit of $0.08 per share; Q3 2026 revenue rises 15% to $154.5 million
  • AtriCure swung to third-quarter 2026 earnings of $0.08 per share from a year-earlier loss.
  • Worldwide revenue rose 15% year over year to $154.5 million.
  • Minimally invasive ablation sales declined as physicians adopted PFA catheters, reducing Hybrid procedures.
  • Full-year 2026 guidance calls for revenue of $606 million to $610 million and earnings per share of $0.21 to $0.27.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AtriCure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001323885-26-000038), on November 03, 2026, and is solely responsible for the information contained therein.